 I believe HRTs vertical focus and penetration of a large and growing market puts the company in a strong position to generate healthy revenue growth over the next several years. HRT trades at a PE multiple of 6x of my FY23 earnings estimate, a discount to both STER and FA, and a sharp discount to a peer group of FinTech. 